Novartis Pharmaceuticals Canada Inc
Novartis is an innovative medicines company dedicated to reimagining medicine to improve and extend people's lives. They focus on addressing serious diseases and have a global reach, with medicines reaching over 250 million people worldwide. The company emphasizes high ethical standards, responsible research, and collaboration with healthcare professionals, patients, and communities to create sustainable value and positive social impact.
Industries
Nr. of Employees
Very Large (1000+)
Novartis Pharmaceuticals Canada Inc
700 St-Hubert, Montreal, Quebec, suite 100, H2Y 0C1
Products
Therapeutic product portfolio (innovative medicines)
A portfolio of approved therapeutic medicines across multiple disease areas offered for patient treatment and distribution.
Research and development pipeline
Pipeline of investigational candidates progressing through discovery, development and regulatory evaluation.
Therapeutic product portfolio (innovative medicines)
A portfolio of approved therapeutic medicines across multiple disease areas offered for patient treatment and distribution.
Research and development pipeline
Pipeline of investigational candidates progressing through discovery, development and regulatory evaluation.
Services
Support for clinical trial recruitment, site collaboration and investigator-initiated research across multiple therapeutic areas.
Programs providing controlled access to investigational therapies for patients who are not eligible for clinical trials.
Telephone and email medical information line for questions about medicinal products and prescriptions.
Online channel for reporting suspected side effects of medicinal products to support pharmacovigilance activities.
Dedicated online portal providing resources and information restricted to licensed healthcare professionals.
Support for clinical trial recruitment, site collaboration and investigator-initiated research across multiple therapeutic areas.
Programs providing controlled access to investigational therapies for patients who are not eligible for clinical trials.
Telephone and email medical information line for questions about medicinal products and prescriptions.
Online channel for reporting suspected side effects of medicinal products to support pharmacovigilance activities.
Dedicated online portal providing resources and information restricted to licensed healthcare professionals.
Expertise Areas
- Clinical trial management
- Pharmacovigilance and safety reporting
- Gene therapy manufacturing
- Biopharmaceutical R&D across oncology, immunology, neuroscience and cardiovascular disease
Key Technologies
- Gene therapy manufacturing
- Biologics development
- Clinical trial platforms and patient recruitment systems
- Pharmacovigilance reporting systems
News & Updates
Novartis announces the company's fourth quarter and 2024 full-year financial results.
Novartis announces the company's fourth quarter and 2024 full-year financial results.